ATTENTION ⚠️
Some institutions were affected last week with having their billing files sent from iLab to their financial system. This has been resolved and files were sent, as one, from iLab to the institution financial system over the weekend. Going forward, files will post as normal, during the regular times that were built with your custom financial integration. If there are any issues with your billng file, open a new help ticket, by clicking on Help at the top right of your account page or by emailing ilab-support@agilent.com.
UCI HRP Policy 15 and the UCIMC Anatomical Pathology/Surgical Pathology - Procedure Number: S-23 click here for a list of exempt specimens) states that no tissues removed from patients at UC Irvine Medical Center may be taken directly from operating rooms or clinics without prior examination by a pathologist, who will determine that which is necessary for diagnostic purposes, and will determine what tissues are remnants that can be used for research purposes.
We can provide the following services:
Compliance with HRP Institutional Review Board (IRB): Investigators will need to provide along with a request the following documents. ETR is required to maintain a copy of all active IRB regulatory documents. Please provide all compliance documents at the time you order service to avoid delays.
Workflow:
If the priority of tissue utilization or the exhaustion of the tissue available is in question, certain requests will need approval of the ETR Tissue Utilization Advisory Committee.
Priority tier for histology services
Cost to Investigator: The activities of the core are underwritten in part by funds from the National Institutes of Health (NIH) in the form of a Cancer Center Support Grant and by the Department of Pathology & Laboratory Medicine. UCI investigators are recharged for the marginal costs associated with processing the request; rates are commensurate to sister institutions’ cores and are subject to annual institutional review.
Acknowledgement Guidelines: It is very important to the continued funding of the Chao Family Comprehensive Cancer Center (CFCCC) that the productive collaboration of CFCCC-supported Shared Resources is acknowledged in publications and presentations, and that resulting publications are processed by the National Institutes of Health Manuscript Submission (NIHMS) to obtain a PubMed Central reference number (PMCID), per NIH Public Access Policy.
Please visit the CFCCC website to learn more about Acknowledging the Cancer Center Support Grant (CCSG) and Shared Resources.
Robert Edwards, MD, PhD | Co-Director | 949-824-8576 | redwards@hs.uci.edu |
Wendy Cozen, DO, MPH | Co-Director | 714-456-5153 | wcozen@hs.uci.edu |
Delia Tifrea, PhD, MBA | Manager | 714-872-1093 | dtifrea@hs.uci.edu |
Name | Role | Phone | Location | |
---|---|---|---|---|
Delia Tifrea, MBA |
ETR Manager
|
714-872-1093
|
dtifrea@hs.uci.edu
|
Douglas hospital, room 3631, UC Irvine Medical Center
|
Jeffrey Kim |
Research Histotechnologist
|
714-456-3389
|
jbkim@uci.edu
|
Building 55, room 334, bay 5 and 6, UC Irvine Medical Center
|
Farah Akhtar |
Electron Microscopist
|
714-456-5022
|
fakhtar@uci.edu
|
Building 54 Room 1107
|
Rodriguez, Christopher |
Research Histotechnologist
|
714.456.5023
|
cjrodri6@hs.uci.edu
|
Building 55, room 334, bay 5 and 6, UC Irvine Medical Center
|